Clinical Trial

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System

Study acronym: TARGET
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety and performance of Cardiovalve TR system
Protocol Amendment History 4 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-12
notable Enrollment increased: 100 -> 157 participants 2026-05-12
notable Primary completion moved earlier: 2026-08-15 -> 2026-03-15 2026-05-12
minor Completion moved earlier: 2033-12-15 -> 2031-12-15 2026-05-12
Trial Details
NCT Number NCT05486832
Lead Sponsor Cardiovalve Ltd.
Conditions Tricuspid Regurgitation
Enrollment 157 participants
Start Date 2022-12-09
Primary Completion 2026-03-15 (estimated)
Study Completion 2031-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-11